Improved culture conditions for the growth and detection of Borrelia from human serum

International Journal of Medical Sciences

Volumn 10, Issue 4, 2013, Pages 362-376

  Sapi, Eva ^a,b   Pabbati, Namrata ^a   Datar, Akshita ^a   Davies, Ellen M ^a   Rattelle, Amy ^a   Kuo, Bruce A ^a  

^a Research Division of Advanced Laboratory Services   (United States)

^b UNIVERSITY OF NEW HAVEN   (United States)

Author keywords

Clinical microbiology; Lyme disease; Spirochetes; Vector borne diseases

Indexed keywords

DNA; MATRIX PROTEIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM DETECTION; BACTERIUM IDENTIFICATION; BORRELIA; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; CULTURE MEDIUM; CULTURE OPTIMIZATION; DNA SEQUENCE; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LYME DISEASE; MAJOR CLINICAL STUDY; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PATIENT SATISFACTION; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; SCHOOL CHILD; SERUM; SPIROCHETE;

CLINICAL MICROBIOLOGY; LYME DISEASE; SPIROCHETES.; VECTOR-BORNE DISEASES;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BORRELIA BURGDORFERI; BORRELIA INFECTIONS; CELL CULTURE TECHNIQUES; CHILD; CHILD, PRESCHOOL; CULTURE MEDIA; FEMALE; HUMANS; LYME DISEASE; MALE; MIDDLE AGED; UNITED STATES;

EID: 84874784835     PISSN: 14491907     EISSN: None     Source Type: Journal    
DOI: 10.7150/ijms.5698     Document Type: Article

References (55)

1. Aguero-Rosenfeld ME, Wang G, Wormser GP, et al. Diagnosis of lyme borreliosis. Clin Microbiol Rev. 2005; 18: 484-509.
2. Marques AR. Lyme Disease: A Review. Curr Allergy Asthma Rep. 2010; 10: 13-20.
3. Bacon RM, Kugeler KJ, Mead PS. Surveillance for Lyme disease-United States, 1992-2006. MMWR Surveill Summ. 2008; 57: 1-9.
4. Stanek G, Wormser GP, Strle F, et al. Lyme borreliosis. Lancet. 2012; 379: 461-73.
5. Worsmer GP, Dattwyler RJ, Steere AC, et al. The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2006; 43: 1089-134.
6. Liegner KB, Shapiro JR, Hogrefe W, et al. Recurrent erythema migrans despite extended antibiotic treatment with minocycline in a patient with persisting Borrelia burgdorferi infection. J American Acad Dermatol. 1993; 28: 312-314.
7. Klempner MS, Hu LT, Johnson GM, et al. Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease. N Engl J Med. 2001; 345: 85-92.
8. Dumler S. Molecular diagnosis of Lyme disease: review and meta-analysis. Mol Diagn. 2001; 6: 1-11.
9. Nelson R. Controversy brewing over Lyme disease testing. Lancet Infect Dis. 2005; 5: 605.
10. Nowakowski J, Schwartz I, Aguero-Rosenfeld ME, et al. Laboratory diagnostic techniques for patients with early Lyme disease associated with erythema migrans: a composition of different techniques. Clin Infect Dis. 2001; 33: 2023-2027.
11. Bunikis J, Barbour AJ. Laboratory testing for suspected Lyme disease. Med Clin North Am. 2002; 86: 311-340.
12. Steere AC, McHugh G, Sikand VK, et al. Prospective study of serologic tests for lyme disease. Clin Infect Dis. 2008; 47: 188-195.
13. Mejri N, Rutti B, Brossard M. Immunosuppressive effects of ixodes ricinus tick saliva or salivary gland extracts on innate and acquired immune response of BALB/c mice. Parasitol Res. 2002; 88: 192-197.
14. Schuijt TJ, Coumou J, Fikrig E, et al. A tick mannose-binding lectin inhibits the vertebrate complement cascade to enhance transmission of the Lyme disease agent. Cell Host Microbe. 2011; 10: 136-146.
15. Hastey CJ, Elsner RA, Baumgarth N, et al. Delays and diversions mark the development of B cell responses to Borrelia burgdorferi infection. J Immun. 2012; 188: 5612-5622.
16. Hardin JA, Steere AC, Malawista SE. Immune complexes and the evolution of Lyme arthritis. Dissemination and localization of abnormal C1q binding activity. N Engl J Med. 1979; 301: 1358-1363.
17. Coyle PK, Schutzer SE, Golightly MG, et al. Cerebrospinal fluid immune complexes in patients exposed to Borrelia burgdorferi: detection of Borrelia-specific and -nonspecific complexes. Ann Neurol. 1990; 28: 739-744.
18. Schutzer SE, Coyle PK, Drulle J, et al. Sequestration of antibody to Borrelia burgdorferi in immune complexes in seronegative Lyme disease. Lancet. 1990; 335: 312-315.
19. Zhong W, Oschmann P, Wellensiek HJ. Detection and preliminary characterization of circulating immune complexes in patients with Lyme disease. Med Microbiol Immunol (Berlin). 1997; 186: 153-158.
20. Wallach FR, Forni AL, Steinberg CR, et al. Circulating Borrelia burgdorferi in patients with acute Lyme disease: results of blood cultures and serum DNA analysis. J Infect Dis. 1993; 168: 1541-1543.
21. Nocton JJ, Bloom BJ, Rutledge BJ, et al. Detection of Borrelia burgdorferi DNA by polymerase chain reaction in cerebrospinal fluid in Lyme neuroborreliosis. J Infect Dis. 1996; 174: 623-627.
22. Rauter C, Mueller M, Hassler D, et al. Critical evaluation of urine-based PCR assay for diagnosis of Lyme borreliosis. Clin Diagn Lab Immunol. 2005; 12: 910-917.
23. Klempner MS, Schmid CH, Hu LT, et al. Intralaboratory reliability of serologic and urine testing for Lyme disease. Am J Med. 2001; 110: 217-219.
24. Al-Soud WA, Radstrom P. Purification and characterization of PCR inhibitory components in blood cells. J Clin Microbio. 2001; 39: 485-493.
25. Molloy PJ, Persing DH, Berardi VP. False-positive results of PCR testing for Lyme disease. Clin Infect Dis. 2001; 33: 412-413.
26. Aguero-Rosenfeld ME, Nadelman RB, Wormser GP, et al. Evolution of the serologic response to Borrelia burgdorferi in treated patients with culture-confirmed erythema migrans. J Clin Microbiol. 1996; 34: 1-9.
27. Barbour AG. Isolation and cultivation of Lyme disease spirochetes. Yale J Biol Med. 1984; 57: 521-525.
28. Liveris D, Wang G, Nowakowski J, et al. Quantitative detection of Borrelia burgdorferi in 2-millimeter skin samples of erythema migrans lesions: correlation of results with clinical and laboratory findings. J Clin Microbiol. 2002; 40: 1249-1253.
29. Cerar T, Rusic-Sabljic E, Strle F, et al. Comparison of PCR methods and culture for the detection of Borrelia spp. in patients with erythema migrans. Clin Microbiol Infect. 2008; 14: 653-658.
30. Liveris D, Nowakowski J, Wormser GP, et al. Comparison of five diagnostic modalities for direct detection of Borrelia burgdorferi in patients with early Lyme disease. Diagn Microbiol and Infect Dis. 2012; 73: 243-245.
31. Casjens S, Palmer N, Stevenson B, et al. A bacterial genome in flux: the twelve linear and nine circular extrachromosomal DNAs in an infectious isolate of the Lyme disease spirochete Borrelia burgdorferi. Mol Microbiol. 2000; 35: 490-516.
32. Pollack R J, Telford III SR, Spielman A. Standardization of medium for culturing Lyme disease spirochetes. J Clin Microbiol. 1993; 31: 1251-1255.
33. Nadelman RB, Nowakowski J, Wormser GP, et al. Failure to isolate Borrelia burgdorferi after antimicrobial therapy in culture-documented Lyme borreliosis associated with erythema migrans: report of a prospective study. Am J Med. 1993; 94: 583-588.
34. Muellegger RR, Zoechling N, Kerl H, et al. No detection of Borrelia burgdorferi-specific DNA in erythema migrans lesions after minocycline treatment. Arch Dermatol. 1995; 131: 678-682.
35. Margos G, Gatewood AG, Terekhova D, et al. MLST of housekeeping genes captures geographic population structure and suggests a European origin of Borrelia burgdorferi. PNAS. 2008; 105: 8730-8735.
36. Tamura K, Peterson D, Nei M, et al. MEGA5: Molecular Evolutionary Genetics Analysis using Maximum Likelihood, Evolutionary Distance, and Maximum Parsimony Methods. Mol Biol Evol. 2011; 28: 2731-2739.
37. Nelson JA, Bouseman JK, Bankowski MJ, et al. Isolation and characterization of Borrelia burgdorferi from Illinois Ixodes dammini. J Clin Microbiol. 1991; 29: 1732-1734.
38. Sapi E, Luecke DF, Kaur N, et al. Evaluation of in vitro antibiotic susceptibility of different morphological forms of Borrelia burgdorferi. Infect Drug Resist. 2011; 4: 97-113.
39. Brorson Ø, Brorson SH. In vitro conversion of Borrelia burgdorferi to cystic forms in spinal fluid, and transformation to mobile spirochetes by incubation in BSK-H medium. Infect. 1998; 26: 44-50.
40. Gruntar I, Malovrh T, Cinco M, et al. Conversion of Borrelia garinii cystic forms to motile spirochetes in vivo. APMIS. 2001; 109: 383-388.
41. Miklossy J, Kasas S, Yu S et al. Persisting atypical and cystic forms of Borrelia burgdorferi and local inflammation in Lyme neuroborreliosis. J Neuroinflammation. 2008; 5:40-58.
42. Preac-Mursic V, Wanner G, Busch V, et al. Formation and cultivation of Borrelia burgdorferi spheroplast L-form variants. Infect. 1996; 24: 218-225.
43. Preac-Mursic V, Wilske B, Reinhardt S. Culture of Borrelia burgdorferi on six solid media. Eur J Clin Microbiol Infect Dis. 1991; 10: 1076-1079.
44. Phillips SE, Mattman LH, Moayad H, et al. A proposal for the reliable culture of Borrelia burgdorferi from patients with chronic Lyme disease, even from those previously aggressively treated. Infect. 1998; 6: 364-367.
45. Rodríguez I, Lienhard R, Jouda F, et al. Evaluation of a modified culture medium for Borrelia burgdorferi sensu lato. Mem Inst Oswaldo Cruz Rio de Janeiro. 2007; 102: 999-1002.
46. De Martino SJ, Sordet C, Piémont Y, et al. Enhanced culture of Borrelia garinii and Borrelia afzelii strains on a solid BSK-based medium in anaerobic conditions. Res Microbiol. 2006; 157: 726-729.
47. Steere AC, Levin RE, Abraham JH 3rd, et al. Treatment of Lyme arthritis. Arthritis & Rheumatism. 1994; 37: 878-888.
48. Zambrano MC, Beklemisheva AA, Cabello FC, et al. Borrelia burgdorferi binds to, invades and colonizes native type I collagen lattices. Infect Immun. 2004; 72: 3138-3146.
49. Cabello FC, Godfrey HP, Newman SA. Hidden in plain sight: Borrelia burgdorferi and the extracellular matrix. Trends Microbiol. 2007; 15: 350-354.
50. Wormser GP, Bittker S, Nadelman RB, et al. Comparison of the yields of blood cultures using serum or plasma from patients with early Lyme disease. J. Clin Microbiol. 2000; 38: 1648-1650.
51. Bakker RD, Li C, Charon NW, et al. Identification of specific chemoattractants and genetic complementation of a Borrelia burgdorferi chemotaxis mutant: flow cytometry-based capillary tube chemotaxis assay. Appl Environ Microbio. 2007; 73: 1180-1188.
52. Battisti JM, Raffel SJ, Schwan TG. A system for sites specific genetic manipulation of the relapsing fever spirochete Borrelia hermsii. Methods Mol Biol. 2008; 431: 69-84.
53. Boylan JA, Lawrence KA, Gherardini FC, et al. Borrelia burgdorferi membranes are the primary targets of reactive oxygen species. Mol Microbiol. 2008; 68: 786-799.
54. Sapi E, Bastian SL, Leucke DF, et al. Characterization of biofilm formation by Borrelia burgdorferi in vitro. PLoS ONE. 2012; 7(10): e48277.
55. Weisburg WG, Barn SM, Lane DJ, et al. 16S ribosomal DNA amplification for phylogenetic study. J Bacteriol. 1991; 173: 697-703.